|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Agenix Ltd., of Brisbane, Australia, said it secured a loan of A$20 million (US$13.1 million) from the Commonwealth Bank in that country. The company, which reported A$9.5 million in cash through June 30, said the added funding would ensure further development of ThromboView, an imaging product that uses radiolabeled antibodies to locate blood clots throughout the body.
o Australian Cancer Technology Pty Ltd., of West Perth, Australia, appointed Paul Hopper CEO and also raised A$2.4 million (US$1.6 million). Hopper spent about 12 years as managing director of Alpha Healthcare Ltd. He also introduced the NutraForte nutraceutical business. Separately, the company ...